)
)
Beam Therapeutics Investor Relations Material
Latest events
Study Update
Beam Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Beam Therapeutics Inc
Access all reports
Segment Data
Access more data
Revenue by
Source
License and collaboration revenue
Expenses by
Financials
Beam Therapeutics Inc. operates as a clinical-stage biotechnology company, which develops base editing technology to treat serious diseases by making precise changes to DNA and RNA. Its portfolio includes target genes that cover oncology, hematology, ophthalmology, liver disease and neurology conditions. The company was founded by David Nelles, Matthew Porteus and Feng Zhang on April 10, 2018 and is headquartered in Cambridge, MA.
Key slides for Beam Therapeutics Inc
Study Update
Beam Therapeutics Inc
Study Update
Beam Therapeutics Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
BEAM
Country
🇺🇸 United States